The standard starting dose is 0.25 mg injected subcutaneously once weekly, increased by 0.25 mg every four weeks based on tolerability and response
Most common side effects (usually mild to moderate and often improve over time) Nausea Vomiting Diarrhea or constipation Stomach pain or bloating Decreased appetite Fatigue or headache (less common) Tips to feel better Eat smaller, more frequent meals
The biological plausibility is peer-reviewed and replicated
Winkle College of Pharmacy, University of Cincinnati, USA - Mohammed Kubas, Assistant Professor/ Clinical Pharmacist Specialist, Lebanese International University (LIU)/ University of Science and Technology Hospital (USTH), Yemen Watch video Digital event video 20 January 2026, 13:00 - 14:30 CET AI in Clinical Pharmacy Practice From Insight to Intervention More As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making, its impact on pharmacy practice is both profound and transformative
At the end of the procedure, you will be shifted to a ward for monitoring
Looking at the absolute figures, this is how the study breaks down: 47 (2.9%) patients on semaglutide experienced a non-fatal heart attack, compared to 64 (3.9%) on placebo
